Spanish Supreme Court provides clarity on patent limitations during invalidity proceedings

In a recent judgment, the Supreme Court clarifies the procedural practice for defendants to raise a patent limitation during invalidity proceedings. In this particular case, the invalidity related to addition of subject matter and lack of inventive step on the patent of the Tiotropium drug.

Background and summary of the case

The case was brought in 2012 by Laboratorios Liconsa S.A. (“Liconsa”) against Boehringer Ingelheim Pharma GmbH &Co (“Boehringer”) before the Barcelona Patent court.

Liconsa filed invalidity proceedings for revocation of Boehringer's patent EP 1.379.220 , validated in Spain under number

Full article available on PatentHub

Latest insights

More Insights

The Law Commission presents its proposals on reform of the Arbitration Act 1996

Oct 03 2023

Read More
Stethoscope and keyboard on blue background

Pet-ential competition concerns in the vet industry? UK watchdog launches review into the veterinary services market

Oct 02 2023

Read More
Curiosity line blue background

Attorney-General's Privacy Review Report: Australian government response flags significant changes on the horizon

Sep 29 2023

Read More